| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS | REGISTER |
|
|
|
|
|||||||||||||
|
|
|||||||||||||||
CHRONIC OBSTRUCTIVE PULMONARY DISEASE |
1 Respiratory Muscle Laboratory, Guy’s, King’s and St Thomas’ School of Medicine, King’s College Hospital, London, UK
2 Royal Brompton Hospital, London, UK
Correspondence to:
Correspondence to:
Dr W Man, Respiratory Muscle Laboratory, Guy’s, King’s and St Thomas’ School of Medicine, King’s College Hospital, Bessemer Road, London SE5 9PJ, UK;
William.man{at}kcl.ac.uk
Background: Although quadriceps weakness is well recognised in chronic obstructive pulmonary disease (COPD), the aetiology remains unknown. In disabled patients the quadriceps is a particularly underused muscle and may not reflect skeletal muscle function as a whole. Loss of muscle function is likely to be equally distributed if the underlying pathology is a systemic abnormality. Conversely, if deconditioning and disuse are the principal aetiological factors, weakness would be most marked in the lower limb muscles.
Methods: The non-volitional technique of supramaximal magnetic stimulation was used to assess twitch tensions of the adductor pollicis, quadriceps, and diaphragm muscles (TwAP, TwQ, and TwPdi) in 22 stable non-weight losing COPD patients and 18 elderly controls.
Results: Mean (SD) TwQ tension was reduced in the COPD patients (7.1 (2.2) kg v 10.0 (2.7) kg; 95% confidence intervals (CI) -4.4 to -1.4; p<0.001). Neither TwAP nor TwPdi (when corrected for lung volume) differed significantly between patients and controls (mean (SD) TwAP 6.52 (1.90) N for COPD patients and 6.80 (1.99) N for controls (95% CI -1.5 to 0.97, p=0.65; TwPdi 23.0 (5.6) cm H2O for COPD patients and 23.5 (5.2) cm H2O for controls (95% CI -4.5 to 3.5, p=0.81).
Conclusions: The strength of the adductor pollicis muscle (and the diaphragm) is normal in patients with stable COPD whereas quadriceps strength is substantially reduced. Disuse may be the principal factor in the development of skeletal muscle weakness in COPD, but a systemic process preferentially affecting the proximal muscles cannot be excluded.
Keywords: skeletal muscle strength; transcutaneous nerve stimulation; chronic obstructive pulmonary disease
This article has been cited by other articles:
|
|
 |
|
  E. B. Swallow, H. R. Gosker, K. A. Ward, A. J. Moore, M. J. Dayer, N. S. Hopkinson, A. M. W. J. Schols, J. Moxham, and M. I. Polkey A novel technique for nonvolitional assessment of quadriceps muscle endurance in humans J Appl Physiol, September 1, 2007; 103(3): 739 - 746. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. B Swallow, D. Reyes, N. S Hopkinson, W. D-C Man, R. Porcher, E. J Cetti, A. J Moore, J. Moxham, and M. I Polkey Quadriceps strength predicts mortality in patients with moderate to severe chronic obstructive pulmonary disease Thorax, February 1, 2007; 62(2): 115 - 120. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W D-C Man, N S Hopkinson, F Harraf, D Nikoletou, M I Polkey, and J Moxham Abdominal muscle and quadriceps strength in chronic obstructive pulmonary disease Thorax, September 1, 2005; 60(9): 718 - 722. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Saey, A. Michaud, A. Couillard, C. H. Cote, M. J. Mador, P. LeBlanc, J. Jobin, and F. Maltais Contractile Fatigue, Muscle Morphometry, and Blood Lactate in Chronic Obstructive Pulmonary Disease Am. J. Respir. Crit. Care Med., May 15, 2005; 171(10): 1109 - 1115. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. D-C Man, M. I Polkey, N. Donaldson, B. J Gray, and J. Moxham Community pulmonary rehabilitation after hospitalisation for acute exacerbations of chronic obstructive pulmonary disease: randomised controlled study BMJ, November 20, 2004; 329(7476): 1209. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W.D-C. Man, J. Moxham, and M.I. Polkey Magnetic stimulation for the measurement of respiratory and skeletal muscle function Eur. Respir. J., November 1, 2004; 24(5): 846 - 860. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W D C Man, N Mustfa, D Nikoletou, S Kaul, N Hart, G F Rafferty, N Donaldson, M I Polkey, and J Moxham Effect of salmeterol on respiratory muscle activity during exercise in poorly reversible COPD Thorax, June 1, 2004; 59(6): 471 - 476. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M I Polkey Peripheral muscle weakness in COPD: where does it come from? Thorax, September 1, 2003; 58(9): 741 - 742. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS | REGISTER |
